USE OF TROP-2 AS PREDICTIVE MARKER OF RESPONSE TO ANTI-TUMOR THERAPY BASED ON INHIBITORS OF CD9, AKT AND MOLECULES OF THE TETRASPANIN SIGNALLING NETWORK
- Application ID: EP13739819
- Status: █ EXAMINATION IN PROGRESS
This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING) Isea SRL is specialized in the combination A61 and G01. We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Dr. Emil Benatov & Partners - Bulgarian Patent Attorney & Licensed Appraiser and 164 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.